Monica Ramello

Trieste, 34129, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI.

Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI.

Journal: Future oncology (London, England)

Published: December 05, 2023

Prognostic value of alkaline phosphatase and gamma-glutamyl transferase in patients with metastatic pancreatic cancer.

Prognostic value of alkaline phosphatase and gamma-glutamyl transferase in patients with metastatic pancreatic cancer.

Journal: Future oncology (London, England)

Published: May 26, 2023

Clinical outcome and safety profile of metastatic pancreatic cancer patients treated with more than six cycles of nab-paclitaxel plus gemcitabine.

Clinical outcome and safety profile of metastatic pancreatic cancer patients treated with more than six cycles of nab-paclitaxel plus gemcitabine.

Journal: Journal of chemotherapy (Florence, Italy)

Published: May 11, 2023

Risk Factors for Nab-Paclitaxel and Gemcitabine-Induced Peripheral Neuropathy in Patients with Pancreatic Cancer.

Risk Factors for Nab-Paclitaxel and Gemcitabine-Induced Peripheral Neuropathy in Patients with Pancreatic Cancer.

Journal: Oncology

Published: January 31, 2022

The impact of age, performance status and comorbidities on nab-paclitaxel plus gemcitabine effectiveness in patients with metastatic pancreatic cancer.

The impact of age, performance status and comorbidities on nab-paclitaxel plus gemcitabine effectiveness in patients with metastatic pancreatic cancer.

Journal: Scientific reports

Published: October 14, 2021

Capecitabine as a Second-line Treatment for Older Patients with Pancreatic Cancer.

Capecitabine as a Second-line Treatment for Older Patients with Pancreatic Cancer.

Journal: Current pharmaceutical biotechnology

Published: October 02, 2021

Association between Low-Grade Chemotherapy-Induced Peripheral Neuropathy (CINP) and Survival in Patients with Metastatic Adenocarcinoma of the Pancreas.

Association between Low-Grade Chemotherapy-Induced Peripheral Neuropathy (CINP) and Survival in Patients with Metastatic Adenocarcinoma of the Pancreas.

Journal: Journal of clinical medicine

Published: February 07, 2021

FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer.

FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer.

Journal: Cancer management and research

Published: June 17, 2020

Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer.

Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer.

Journal: Scientific reports

Published: June 16, 2020

The value of patient centred care in oncology.

The value of patient centred care in oncology.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: May 31, 2020

Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study.

Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study.

Journal: Current cancer drug targets

Published: May 27, 2020

Surgical oncology in the elderly.

Surgical oncology in the elderly.

Journal: Acta chirurgica Belgica

Published: July 23, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026